Search - tctmd.com

Displaying 221 - 240 of 3304

Sort: Relevancy | Date

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

Shelley Wood

September 02, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Caitlin E. Cox

August 28, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

Shelley Wood

August 23, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

Todd Neale

August 15, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

Advertisement

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

TCTMD’s Top 10 Most Popular Stories for August 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

September 2024 Dispatch for the CV Team

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Scientific Statement Reviews Current Antithrombotic Options in PAD

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

What’s Going to Be Hot at ESC 2024

Platelet Hyperreactivity Score May Improve CVD Risk Detection

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Going Contrast Free in TAVI Is Safe for CKD Patients

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

DES Best for In-Stent Restenosis, but DCBs Also Viable

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content